Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhipu Runchang is a Traditional Chinese Medicine (TCM) candidate developed by Suzhou Aifeitang Pharmaceutical Technology for the treatment of functional constipation. Formulated as an oral capsule, it is classified as an innovative TCM drug (formerly Class 6 under NMPA regulations). The preparation is designed to alleviate symptoms of chronic constipation by moistening the intestinal tract and promoting bowel movements through the synergistic effects of its plant-derived components. Clinical development has reached Phase 2 in China, where it is being evaluated for its safety and therapeutic efficacy in patients with functional constipation. It represents a modernized approach to traditional herbal therapy, aiming for standardized production and clinical validation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhipu Runchang.